IRIS

We outline an ambitious project to characterize the genetic and epigenetic regulation of multiple facets of transcription in distinct brain regions across the human lifespan in samples of major neuropsychiatric disorders and controls. Initially focused on schizophrenia and mood disorders, the goal of this consortium is to elucidate the underlying molecular mechanisms of genetic associations with the goal of identifying novel therapeutic targets. The consortium currently consists of seven pharmaceutical companies and a not-for-profit medical research institution working as a precompetitive team to generate and analyze publicly available archival brain genomic data related to neuropsychiatric illness.

BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders / Schubert, C. R.; O'Donnell, P.; Quan, J.; Wendland, J. R.; Xi, H. S.; Winslow, A. R.; Domenici, E.; Essioux, L.; Kam-Thong, T.; Airey, D. C.; Calley, J. N.; Collier, D. A.; Wang, H.; Eastwood, B.; Ebert, P.; Liu, Y.; Nisenbaum, L.; Ruble, C.; Scherschel, J. E.; Smith, R. M.; Qian, H. R.; Merchant, K.; Didriksen, M.; Matsumoto, M.; Saito, T.; Brandon, N. J.; Cross, A. J.; Wang, Q.; Manji, H.; Kolb, H.; Furey, M.; Drevets, W. C.; Shin, J. H.; Jaffe, A. E.; Jia, Y.; Straub, R. E.; Deep-Soboslay, A.; Hyde, T. M.; Kleinman, J. E.; Weinberger, D. R.. - In: NEURON. - ISSN 0896-6273. - 88:6(2015), pp. 1078-1083. [10.1016/j.neuron.2015.10.047]

BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders

DOMENICI, E.;Wang, Q.;
2015-01-01

Abstract

We outline an ambitious project to characterize the genetic and epigenetic regulation of multiple facets of transcription in distinct brain regions across the human lifespan in samples of major neuropsychiatric disorders and controls. Initially focused on schizophrenia and mood disorders, the goal of this consortium is to elucidate the underlying molecular mechanisms of genetic associations with the goal of identifying novel therapeutic targets. The consortium currently consists of seven pharmaceutical companies and a not-for-profit medical research institution working as a precompetitive team to generate and analyze publicly available archival brain genomic data related to neuropsychiatric illness.
2015
NEURON
6
26687217
2-s2.0-84961616869
WOS:000368443900005
Schubert, C. R.; O'Donnell, P.; Quan, J.; Wendland, J. R.; Xi, H. S.; Winslow, A. R.; Domenici, E.; Essioux, L.; Kam-Thong, T.; Airey, D. C.; Calley, J. N.; Collier, D. A.; Wang, H.; Eastwood, B.; Ebert, P.; Liu, Y.; Nisenbaum, L.; Ruble, C.; Scherschel, J. E.; Smith, R. M.; Qian, H. R.; Merchant, K.; Didriksen, M.; Matsumoto, M.; Saito, T.; Brandon, N. J.; Cross, A. J.; Wang, Q.; Manji, H.; Kolb, H.; Furey, M.; Drevets, W. C.; Shin, J. H.; Jaffe, A. E.; Jia, Y.; Straub, R. E.; Deep-Soboslay, A.; Hyde, T. M.; Kleinman, J. E.; Weinberger, D. R.
BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders / Schubert, C. R.; O'Donnell, P.; Quan, J.; Wendland, J. R.; Xi, H. S.; Winslow, A. R.; Domenici, E.; Essioux, L.; Kam-Thong, T.; Airey, D. C.; Calley, J. N.; Collier, D. A.; Wang, H.; Eastwood, B.; Ebert, P.; Liu, Y.; Nisenbaum, L.; Ruble, C.; Scherschel, J. E.; Smith, R. M.; Qian, H. R.; Merchant, K.; Didriksen, M.; Matsumoto, M.; Saito, T.; Brandon, N. J.; Cross, A. J.; Wang, Q.; Manji, H.; Kolb, H.; Furey, M.; Drevets, W. C.; Shin, J. H.; Jaffe, A. E.; Jia, Y.; Straub, R. E.; Deep-Soboslay, A.; Hyde, T. M.; Kleinman, J. E.; Weinberger, D. R.. - In: NEURON. - ISSN 0896-6273. - 88:6(2015), pp. 1078-1083. [10.1016/j.neuron.2015.10.047]
File in questo prodotto:
File Dimensione Formato  
Schubert et al Neuron 2015.pdf

Solo gestori archivio

Tipologia: Versione editoriale (Publisher’s layout)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 938.31 kB
Formato Adobe PDF
  Visualizza/Apri
938.31 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/125537
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus 73
  • ???jsp.display-item.citation.isi??? 46
social impact